BiopharmaVantage is delighted to announce that it has acted as advisor for an in vitro diagnostics business seeking further growth opportunities. The company is based in the UK but has global customers base and leverages a state-of-the-art platform to deliver its products and services.

BiopharmaVantage’s lead advisor, Dr Shreesh Saurya, managing the engagement commented: "It is vital that growth strategies and associated options are considered from the perspective of various stakeholders and investors. Our methodology not only helped to eliminate pseudo growth options but also helped to identify genuine value maximising strategy that is aligned with the objectives of this company. Successful execution strategy that we have put in place, would allow the company to grow, transform and add tangible value to all its stakeholders.”

About BiopharmaVantage

BiopharmaVantage is a consultancy that specialises in providing strategic advice, market dynamics, commercial due diligence and transaction services in the area of healthcare, life sciences, medical devices and diagnostics. If you would like to discuss how we can assist you, then please contact us.

Contact: Julie Kalash, Business Development Manager, BiopharmaVantage, Oxford, UK

Email: [email protected]

Website: http://www.biopharmavantage.com